The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)May 14, 2026 — This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.
May 14, 2026 — BluSky AI (OTCID: BSAI) announced the launch of a Regulation A+ offering aimed at enabling individual and accredited investors to participate in the company’s planned expansion of its distributed AI infrastructure network, with a minimum investment of $1,000. Proceeds are intended to support development of BluSky AI’s modular AI Factory footprint across the United States, including expansion of its Neocloud compute capacity designed to serve growing demand for large-scale AI training and inference workloads.
May 14, 2026 — American Fusion (OTC: AMFN) provided an update on recent strategic engagements in Washington, D. C.
May 14, 2026 — NextPlat (NASDAQ: NXPL, NXPLW) reported improved first-quarter 2026 operating results as ongoing turnaround initiatives drove stronger margins and reduced losses despite lower year-over-year revenue. The company posted quarterly revenue of $9.
May 14, 2026 — Aditxt (NASDAQ: ADTX), a social innovation platform accelerating health innovations, announced it will implement a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The reverse split is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement, reducing outstanding common shares from approximately 13.
May 14, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) announced its featured placement in a BioMedWire editorial focused on emerging CNS drug delivery technologies addressing challenges in Alzheimer’s disease and biodefense research. The editorial highlights the company’s proprietary intranasal nose-to-brain delivery platform, designed to bypass the blood-brain barrier and enable direct therapeutic delivery to the central nervous system, reflecting growing interest in advanced drug delivery approaches for neurological treatment.
May 14, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
May 14, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
May 14, 2026 — Chinese authorities are implementing regulations to formalize electric vehicle battery recycling markets as informal operations have captured roughly 70% of retired battery volumes, creating safety and environmental concerns. New EV battery recycling rules would require end-of-life batteries to remain with vehicles through authorized recycling channels, rather than entering unregulated networks where small operators disassemble and resell components.
May 14, 2026 — New research funded by the NIH has uncovered a link between androgens in men and brain tumors. The preclinical study found that men with low levels of testosterone tended to have shorter survival times when diagnosed with glioblastoma when compared to those that had higher levels of this male sex hormone.
May 14, 2026 — As major technology companies pour billions into AI, two of the sector’s biggest names are increasingly turning to overseas debt markets to support rising costs tied to the fast-moving AI race. As AI systems become more advanced, companies like Datavault AI Inc.
May 14, 2026 — This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.
May 14, 2026 — CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results while outlining progress in its strategic transformation toward an acquisition-driven growth model focused on clinical-stage neurology and oncology assets. Following quarter end, the company strengthened its balance sheet with a $22.
May 14, 2026 — This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.
May 14, 2026 — Kairos Pharma (NYSE American: KAPA) announced it has been named a winner in the 2026 GHP Magazine Healthcare & Pharmaceutical Awards, receiving recognition as the USA leader in drug resistance development. The award highlights the company’s work in advancing cancer therapeutics designed to address treatment resistance, underscoring Kairos’ focus on extending the effectiveness of existing cancer therapies through innovative drug resistance-targeting approaches.
May 14, 2026 — BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.
May 14, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) announced a poster presentation at ISPOR 2026 highlighting findings from a retrospective cohort study analyzing U. S.
May 14, 2026 — This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.
May 14, 2026 — This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.
May 14, 2026 — HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U. S.